Table 8 The Formulations Systems and Major Excipients of the Selected Commercial COE Products
Product No | Product name | Formulation system | Major ingredients in the formulation | Reference |
|---|---|---|---|---|
1 | Surolan | Nonaqueous system | silica colloidal anhydrous and liquid paraffin | Summary of product characteristics (Elanco Europe Ltd) |
2 | Dermotic | Nonaqueous system | paraffin oils and paraffin wax | Summary of product characteristics (Troy Laboratories Pty Ltd) |
3 | Mometamax | Nonaqueous system | mineral oil polyethylene | Product material safety data (Intervet Inc.) |
4 | Easotic | Nonaqueous system | liquid paraffin | Summary of product characteristics (Virbac) |
5 | Canaural | Nonaqueous system | sesame oil | Summary of product characteristics (Dechra) |
6 | Osurnia | Nonaqueous system | butylhydroxytoluene (e 321) hypromellose lecithin oleic acid propylene carbonate glycerol formal | Summary of product characteristics (Elanco Europe Ltd) |
7 | Baytril Otic | emulsion system | benzyl alcohol cetylstearyl alcohol a neutral oil purified water emulsion | Product description (Bayer HealthCare LLC) |
8 | Aurizon Ear Drops | Nonaqueous system | propyl gallate (e310), sorbitan oleate silica, colloidal hydrophobic triglycerides, medium-chain | Summary of product characteristics (Vetoquinol UK Limited) |
9 | Apex PMP | Nonaqueous systema | - | Product material safety data sheet (Apex Laboratories Pty Ltd), |